Market World Orthobiologics Market Overview | Page 2

fuels the demand for orthobiologics treatment. The bone graft procedure accounted to be the largest segment
in the global orthobiologics market.
The shifting preference to biological implants from mechanical implants is accelerating the growth of this
market. Another important trend that is estimated to enhance the growth of the market over next eight years
is the increase in funds to improve orthobiologics. Factors such as growing advances in technology, the
prevalence of a huge number of chronic and unidentified diseases, initiatives by the government and rise in life
expectation may favorably impact the market growth. Along with this, the rising incidences of injuries by sports
& road accidents and growing awareness among athletes are also driving the demand for the market.
However, lack of clear reimbursement procedures and rigorous rules may create major hindrances for the
orthobiologics demand in the market. The improvements in developing alternatives for pharmaceuticals, for
making medical treatments more preventive than curative along with the country’s policy for decreasing the
deficit in the budget is expected to negatively impact the global orthobiologics market. Furthermore, high costs
for the procedure, lack of reliable clinical trial data and strict regulations for the approval of orthobiologics
products may pose challenges to the market growth over the forecast period.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/orthobiologics-market
The global orthobiologics market has been segmented based on its applications and product types. On the basis
of application, the market been classified into spinal surgery, joint replacement & reconstruction, and trauma
surgery. On the basis of product types, the market has been segmented into bone graft substitutes, bone growth
stimulators, and viscosupplements. The bone graft substitutes have further been segmented into demoralized
bone matrix (DBM), bone morph genic proteins (BMP), bone allografts, and bone autographs. Additionally,
viscosupplements has also been further segmented into single injection viscosupplements, 3-injection
viscosupplements, and 5-injection viscosupplements.
Over the past few years, the viscosupplements segments held the largest market share for orthobiologics on
account of huge demand for knee treatment procedures. It is a very effective pain killer. Viscosupplements are
intra-articular injections made of hyaluronic acid which helps in the treatment of osteoarthritis.
North America held the majority of the global orthobiologics market in the recent past. The high demand in the
market was sustained by increased prevalence of arthritis and obesity in the region, rising demand for the
treatment of various diseases such as osteoarthritis and spinal injuries. However, over the next eight years, Asia-
Pacific is projected to witness the highest rate of growth for orthobiologics market. This growth will be majorly
driven by the Indian and Chinese market on account of a huge number of untapped patient population,
economical cost, and medical tourism.